|
|
||||||||
Immunodominant antigens of an approximate molecular mass of 27 kD were obtained from an excretory-secretory product of adult Fasciola gigantica by a continuous-elution method. An indirect ELISA using the antigens obtained by this relatively simple procedure was developed for detecting specific antibodies from patients infected with F. gigantica. Sera from patients with other parasitic infections, healthy volunteers, and cholangiocarcinoma were also analyzed. The sensitivity, specificity, and positive and negative predictive values for this ELISA using the fractionated antigens were 100%. The data indicated a possible correlation of antibodies to F. gigantica with cholangiocarcinoma.
This article has been cited by other articles:
![]() |
T. H. Le, N. V. De, T. Agatsuma, D. Blair, J. Vercruysse, P. Dorny, T. G. T. Nguyen, and D. P. McManus Molecular Confirmation that Fasciola gigantica Can Undertake Aberrant Migrations in Human Hosts J. Clin. Microbiol., February 1, 2007; 45(2): 648 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wongkham, C. Tantrawatpan, P. M. Intapan, W. Maleewong, S. Wongkham, and K. Nakashima Evaluation of Immunoglobulin G Subclass Antibodies against Recombinant Fasciola gigantica Cathepsin L1 in an Enzyme-Linked Immunosorbent Assay for Serodiagnosis of Human Fasciolosis Clin. Vaccine Immunol., October 1, 2005; 12(10): 1152 - 1156. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. TANTRAWATPAN, W. MALEEWONG, C. WONGKHAM, S. WONGKHAM, P. M. INTAPAN, and K. NAKASHIMA SERODIAGNOSIS OF HUMAN FASCIOLIASIS BY A CYSTATIN CAPTURE ENZYME-LINKED IMMUNOSORBENT ASSAY WITH RECOMBINANT FASCIOLA GIGANTICA CATHEPSIN L ANTIGEN Am J Trop Med Hyg, January 1, 2005; 72(1): 82 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Y. Kim, S.-Y. Kang, S. H. Park, K. Sukontason, K. Sukontason, and S.-J. Hong Cystatin Capture Enzyme-Linked Immunosorbent Assay for Serodiagnosis of Human Clonorchiasis and Profile of Captured Antigenic Protein of Clonorchis sinensis Clin. Vaccine Immunol., November 1, 2001; 8(6): 1076 - 1080. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |